BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossignol DA, Frye RE. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J Pers Med 2021;11:1141. [PMID: 34834493 DOI: 10.3390/jpm11111141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Ravaei A, Rubini M. Folate in maternal rheumatoid arthritis-filial autism spectrum disorder continuum. Reprod Toxicol 2023;115:29-35. [PMID: 36402436 DOI: 10.1016/j.reprotox.2022.11.004] [Reference Citation Analysis]
2 Yang MT, Chou IC, Wang HS. Role of vitamins in epilepsy. Epilepsy Behav 2022;139:109062. [PMID: 36577336 DOI: 10.1016/j.yebeh.2022.109062] [Reference Citation Analysis]
3 Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA. The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment. J Pers Med 2022;12. [PMID: 36556254 DOI: 10.3390/jpm12122033] [Reference Citation Analysis]
4 Uddin MN, Manley K, Lawrence DA. Altered meningeal immunity contributing to the autism-like behavior of BTBR T Itpr3/J mice. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100563] [Reference Citation Analysis]
5 Phichaya P, Wararat C, Somchai C, Oraporn D, Palisara T, Witchaya B, Jariya C. Folate Receptor Alpha Autoantibodies in Children with Autism Spectrum Disorder. Biomarkers. [DOI: 10.1080/1354750x.2022.2125579] [Reference Citation Analysis]
6 Li B, Xu Y, Pang D, Zhao Q, Zhang L, Li M, Li W, Duan G, Zhu C. Interrelation between homocysteine metabolism and the development of autism spectrum disorder in children. Front Mol Neurosci 2022;15:947513. [DOI: 10.3389/fnmol.2022.947513] [Reference Citation Analysis]
7 Jensen AR, Lane AL, Werner BA, McLees SE, Fletcher TS, Frye RE. Modern Biomarkers for Autism Spectrum Disorder: Future Directions. Mol Diagn Ther 2022. [PMID: 35759118 DOI: 10.1007/s40291-022-00600-7] [Reference Citation Analysis]
8 Cai C, Yin Z, Liu A, Wang H, Zeng S, Wang Z, Qiu H, Li S, Zhou J, Wang M. Identifying Rare Genetic Variants of Immune Mediators as Risk Factors for Autism Spectrum Disorder. Genes (Basel) 2022;13:1098. [PMID: 35741860 DOI: 10.3390/genes13061098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rossignol DA, Frye RE. Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141. JPM 2022;12:721. [DOI: 10.3390/jpm12050721] [Reference Citation Analysis]
10 Brister D, Werner BA, Gideon G, Mccarty PJ, Lane A, Burrows BT, Mclees S, Adelson PD, Arango JI, Marsh W, Flores A, Pankratz MT, Ly NH, Flood M, Brown D, Carpentieri D, Jin Y, Gu H, Frye RE. Central Nervous System Metabolism in Autism, Epilepsy and Developmental Delays: A Cerebrospinal Fluid Analysis. Metabolites 2022;12:371. [DOI: 10.3390/metabo12050371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Frye RE. A Personalized Multidisciplinary Approach to Evaluating and Treating Autism Spectrum Disorder. JPM 2022;12:464. [DOI: 10.3390/jpm12030464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Panisi C, Marini M. Dynamic and Systemic Perspective in Autism Spectrum Disorders: A Change of Gaze in Research Opens to A New Landscape of Needs and Solutions. Brain Sciences 2022;12:250. [DOI: 10.3390/brainsci12020250] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Frye RE, Rose S, Boles RG, Rossignol DA. A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder. JPM 2022;12:147. [DOI: 10.3390/jpm12020147] [Reference Citation Analysis]